Biohaven Pharma (BHVN) PT Lowered to $30 at Raymond James
Tweet Send to a Friend
Raymond James analyst Chris Raymond lowered the price target on Biohaven Pharma (NYSE: BHVN) to $30.00 (from $50.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
